⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6849084 | 1.00 | — | — | |
| SCHEMBL6137266 | 0.98 | — | — | |
| SCHEMBL666848 | 0.77 | — | — | |
| SCHEMBL8387047 | 0.77 | — | — | |
| SCHEMBL1420238 | 0.74 | — | — | |
| Bromide SCHEMBL29004090 | 0.69 | — | — | |
| SCHEMBL26965454 | 0.69 | — | — | |
| SCHEMBL3330004 | 0.69 | MEN1 (0.31) | — | |
| SCHEMBL28797319 | 0.68 | — | — | |
| SCHEMBL15213283 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113150358-B | Conductive fluorosilicone rubber foam composite material and preparation method and application thereof | 杭州师范大学 | 2022-06-28 | — | — | CN | disclosed |
| CN-111138864-B | Fluorine-containing oil-resistant anti-swelling silicone rubber foam material and preparation method thereof | 杭州师范大学 | 2022-03-08 | — | — | CN | disclosed |
| CN-113150358-A | Conductive fluorosilicone rubber foam composite material and preparation method and application thereof | 杭州师范大学 | 2021-07-23 | — | — | CN | disclosed |
| CN-111138864-A | Fluorine-containing oil-resistant anti-swelling silicone rubber foam material and preparation method thereof | 杭州师范大学 | 2020-05-12 | — | — | CN | disclosed |
| US-6822112-B1 | PROSTAGLANDIN D2 AGONISTS; KIDNEY, CARDIOVASCULAR, AND SLEEP DISORDERS; ANTIISCHEMIC AND HYPOTENSIVE AGENTS | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2004-11-23 | — | — | US | disclosed |
| EP-0805682-B1 | DERMATOLOGICAL USE OF VITAMIN D DERIVATIVES | BASILEA PHARMACEUTICA AG (CH) | 2004-08-11 | — | — | EP | disclosed |
| EP-1219600-A1 | PROSTAGLANDIN DERIVATIVES | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2002-07-03 | — | — | EP | disclosed |
| US-5827883-A | TOPICAL DRUG DELIVERY; SIDE EFFECT REDUCTION | HOFFMANN-LA ROCHE INC. (US) | 1998-10-27 | — | — | US | disclosed |
| EP-0805682-A1 | DERMATOLOGICAL USE OF VITAMIN D DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1997-11-12 | — | — | EP | disclosed |
| WO-1996022776-A1 | DERMATOLOGICAL USE OF VITAMIN D DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1996-08-01 | — | — | WO | disclosed |